KRISTEN KING: Open Payments
NPI 1003301375 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 32 payments from 12 companies in 2025. Trend: 2023 $627 · 2024 $605 · 2025 $1,106
Food & beverage: $1,106
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 7 | $351 |
| Axsome Therapeutics, Inc. | 4 | $146 |
| Baxter Healthcare | 1 | $120 |
| ABBVIE INC. | 6 | $109 |
| Boston Scientific Corporation | 2 | $109 |
| Biosense Webster, Inc. | 3 | $63 |
| Medtronic, Inc. | 1 | $63 |
| Novo Nordisk Inc | 3 | $52 |
| Abbott Laboratories | 2 | $39 |
| Antares Pharma, Inc. | 1 | $20 |
Products named: Xeomin, Auvelity, TISSEEL, WATCHMAN FLX, VRAYLAR, NA, SYMPLICITY G3, Ozempic.
Industry payments across LA — which companies pay providers there.
